|
|
| |
| Most Discussed Stocks |
 |
|
|
|
| |
|
News |
| |
|
WILL THE FDA GIVE THE GREEN LIGHT T.... |
10/06/2008 |
|
Has the time come for Provenge, the prostate cancer vaccine developed by Dendreon, to be given marketing approval so it can save condemned metastatic prostate cancer patients’ lives? |
| |
|
PROGENICS: THE HIV DRUG LOOKS PROMI.... |
10/02/2008 |
|
|
| |
|
WE WILL BE ALL RIGHT |
09/25/2008 |
|
We gave you Sequenom and many other winners. Prohost will continue to do the same, hopefully without as much struggling against the greed of those who took advantage of the market deregulation to turn it into a vehicle for self-fulfillment of destructive prophesies at the expense of the serious investors.
We surely believe that America is capable of overcoming this crisis. Yet, our hope is in a reform that stops the greed that tarnished the market’s and America’s strong economy’s reputation.
We will be all right.
|
| |
|
SEQUENOM (SQNM): SUCCESS OF NON INV.... |
09/24/2008 |
|
The results are 100% without manipulation of the fetus and with a simple mother\'s blood test. |
| |
|
CYTRX COMPLETES ITS BUYOUT OF INNOV.... |
09/23/2008 |
|
Cytrx inherited the cancer drug tamibarotene, which has been approved in Japan for acute promyelocytic leukemia (APL). It also inherited three other drug candidates. Read about tamibarotene. Read also about the a stool test that shows successful results in diagnosing colorectal cancer. |
| |
|
|
| |
| |
| |
|
|
Stocks >> Stocks Details |
|
ALIOF
|
| |
|
ENDOTHELIUM AND ENDOTHELIUM DISEASES |
|
|
|
ACTELION
|
| |
|
Actelion discovers and develops
drugs based on its research of the endothelium, the single layer of cells between
blood vessels and the blood that flows through them. The endothelium has been
linked to such disorders as cancer and cardiovascular and inflammatory
diseases. Actelion has two products on the market, Tracleer for pulmonary
arterial hypertension, and Zavesca for Gaucher disease, a genetic metabolic disorder. Actelion has pulled the
plug on Valetri, which failed to improve blood flow in acute heart failure
patients. The company is also working on potential treatments for other
cardiovascular conditions, cancer, and other disease targets. www.actelion.com.
|
| |
| |
| |
| |
| |
| |
|
|
|
|
